Your browser doesn't support javascript.
loading
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors.
Harding, James J; Jungels, Christiane; Machiels, Jean-Pascal; Smith, David C; Walker, Chris; Ji, Tao; Jiang, Ping; Li, Xin; Asatiani, Ekaterine; Van Cutsem, Eric; Abou-Alfa, Ghassan K.
Afiliação
  • Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA. Hardinj1@mskcc.org.
  • Jungels C; Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA. Hardinj1@mskcc.org.
  • Machiels JP; Department of Oncologic Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Smith DC; Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 10, 1200, Brussels, Belgium.
  • Walker C; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Ji T; Incyte Corporation, Wilmington, DE, USA.
  • Jiang P; Incyte Corporation, Wilmington, DE, USA.
  • Li X; Incyte Corporation, Wilmington, DE, USA.
  • Asatiani E; Incyte Corporation, Wilmington, DE, USA.
  • Van Cutsem E; Incyte Biosciences International Sàrl, Morges, Switzerland.
  • Abou-Alfa GK; Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium.
Target Oncol ; 18(2): 181-193, 2023 03.
Article em En | MEDLINE | ID: mdl-36787089

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hepáticas / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hepáticas / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos